EMD-49762

Single-particle
7.45 Å
EMD-49762
3D View Gallery
Deposition: 18/03/2025
Map released: 14/01/2026
Last modified: 14/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-49762
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9ntt summary report (pdf.gz) Map and 9ntt FULL report (pdf.gz)
EMICSS annotations (xml)

Identification and non-clinical characterization of SAR444200, a novel anti-GPC3 T-cell engager for the treatment of GPC3+ solid tumors

EMD-49762

Single-particle
7.45 Å
EMD-49762
3D View Gallery
Deposition: 18/03/2025
Map released: 14/01/2026
Last modified: 14/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Lama glama
Sample: GPC3 A0226018C08 complex
Fitted models: 9ntt

Deposition Authors: Batchelor JD , Svidritskiy E
Identification and non-clinical characterization of SAR444200, a novel anti-GPC3 NANOBODY® T-cell engager, for the treatment of GPC3+ solid tumors.
Meoni P , Vintem APB , Cortez-Retamozo VF , Jacobs J , De Tavernier E , Fiorentini P , Van Hoorick D , Batchelor JD , Svidritskiy E , Qiu Y , Dejonckheere E , Li A , Pao LI , Buyse MA
(2025) Mol.Cancer Ther.
PUBMED: 41041827
DOI: doi:10.1158/1535-7163.MCT-24-1049
ISSN: 1538-8514
Grant Support: